Latest News and Press Releases
Want to stay updated on the latest news?
-
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
-
NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals Inc.,...
-
NEW YORK, April 11, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals Inc.,...
-
NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals Inc.,...
-
NEW YORK, March 28, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Vanda Pharmaceuticals Inc.,...
-
NEW YORK, March 03, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Diplomat Pharmacy, Inc.,...
-
NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on...
-
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). Our investigation concerns whether...
-
NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). Our investigation concerns whether...